About nicky

This author has not yet filled in any details.
So far has created 17 blog entries.

Health Investor Awards 2017

Professor Gordon Wishart, Check4Cancer’s Chief Medical Officer, is delighted to announce that Check4Cancer and Cigna UK have been shortlisted...
February 22nd, 2017|Check4Cancer, Cigna|

American Joint Committee on Cancer

In November 2016, The PREDICT survival model (www.predict.nhs.uk) was one of only two breast cancer prognostic models out of 30 reviewed...
November 25th, 2016|Breast Cancer|

XX Russian Oncology Congress

On 17 November 2016, Professor Gordon Wishart gave an invited presentation on “Sentinel node biopsy in early breast cancer” at the XX Russian Oncology Conference in Moscow.
November 25th, 2016|Breast Cancer|

Skin Cancer Diagnostic Network

In May 2016, Check4Cancer’s Chief Medical Officer Professor Gordon Wishart launched a nurse-led skin cancer diagnosis service for Cigna-insured patients.
May 25th, 2016|Check4Cancer|

OneStop Diagnostic Breast Network

On 4 January 2016, Check4Cancer launched a OneStop diagnostic breast network for Cigna insured clients via its BreastHealth UK brand.
January 8th, 2016|Check4Cancer|

Cigna and BreastHealth Uk join forces

On 8 October 2015 Cigna UK HealthCare Benefits (Cigna) and BreastHealth UK formed an alliance to offer Cigna customers OneStop breast cancer diagnostics from beginning January 2016.
October 14th, 2015|BreastHealth UK, Cigna|

New state of the art hospital in central Cambridge

On 27 July 2015, the Nuffield Health opened its brand new state of the art hospital in central Cambridge.
July 15th, 2015|Nutfield Health|

Meeting with the Greek Minister of Health

On Monday 6 October 2014, Professor Gordon Wishart, Professor of Cancer Surgery at Anglia Ruskin University & Medical Director of Check4Cancer, was invited to a meeting with the Greek Minister of Health, Mr Mavroudis Voridis in Athens.
October 14th, 2014|Government Campaign|

Exciting early results from NHS lung cancer screening trial

Early results from the largest ever randomised trial for lung cancer, using a blood test that detects autoantibody biomarkers, will be released on 7th September at the International Association for the Study of Lung Cancer’s 16th World Conference on Lung Cancer.
September 27th, 2014|Check4Cancer|

NHS Lung Cancer screening trail

Early results from the largest ever randomised trial for lung cancer, using a blood test that detects autoantibody biomarkers, will be released on 7th September at the International Association for the Study of Lung Cancer’s 16th World Conference on Lung Cancer.
September 14th, 2014|NHS|